| Dr Jimmy Viet Ninh, MD | |
|
10400 75th St, Kenosha, WI 53142-7884 | |
| (262) 948-7815 | |
| Not Available |
| Full Name | Dr Jimmy Viet Ninh |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 20 Years |
| Location | 10400 75th St, Kenosha, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104088939 | NPI | - | NPPES |
| 216585403 | Medicaid | TX | |
| 32826200 | Medicaid | WI | |
| 036116615 | Medicaid | IL | |
| 216585404 | Medicaid | TX |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Medical Center Kenosha | Kenosha, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
Bravo Health today announced that the first Bravo Health Advanced Care Center (the Center) will open in Philadelphia in January 2010. The Center, an innovative, state-of-the-art outpatient physician practice designed to meet the health care needs of Bravo Health members, will be located in a new building being constructed at 1010 W. Lehigh Avenue in North Philadelphia.
Thanks to a discovery by a Saint Louis University researcher, scientists have identified an important microRNA that may allow us to better control cholesterol levels in blood.
A novel study published in the American College of Rheumatology journal, Arthritis & Rheumatism, shows that smaller micropolitan areas of the U.S.-those with less than 50,000 people-have very few or no practicing adult rheumatologist. In some of these areas, individuals have to travel more than 200 miles to reach the closest rheumatologist.
Daiichi Sankyo Company, Limited today announced that it has started enrolling patients into the ENSURE-AF multinational phase 3 study, which will evaluate the efficacy and safety of its investigational oral, once-daily direct factor Xa-inhibitor edoxaban compared to enoxaparin/warfarin for the prevention of stroke and other blood clot complications in patients with non-valvular atrial fibrillation (NVAF) undergoing electrical cardioversion (low-energy shocks to trigger normal heart rhythm).
› Verified 1 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Bravo Health today announced that the first Bravo Health Advanced Care Center (the Center) will open in Philadelphia in January 2010. The Center, an innovative, state-of-the-art outpatient physician practice designed to meet the health care needs of Bravo Health members, will be located in a new building being constructed at 1010 W. Lehigh Avenue in North Philadelphia.
Thanks to a discovery by a Saint Louis University researcher, scientists have identified an important microRNA that may allow us to better control cholesterol levels in blood.
A novel study published in the American College of Rheumatology journal, Arthritis & Rheumatism, shows that smaller micropolitan areas of the U.S.-those with less than 50,000 people-have very few or no practicing adult rheumatologist. In some of these areas, individuals have to travel more than 200 miles to reach the closest rheumatologist.
Daiichi Sankyo Company, Limited today announced that it has started enrolling patients into the ENSURE-AF multinational phase 3 study, which will evaluate the efficacy and safety of its investigational oral, once-daily direct factor Xa-inhibitor edoxaban compared to enoxaparin/warfarin for the prevention of stroke and other blood clot complications in patients with non-valvular atrial fibrillation (NVAF) undergoing electrical cardioversion (low-energy shocks to trigger normal heart rhythm).
› Verified 1 days ago
| Entity Name | Gundersen Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851343115 PECOS PAC ID: 9638082779 Enrollment ID: O20031106000139 |
News Archive
Bravo Health today announced that the first Bravo Health Advanced Care Center (the Center) will open in Philadelphia in January 2010. The Center, an innovative, state-of-the-art outpatient physician practice designed to meet the health care needs of Bravo Health members, will be located in a new building being constructed at 1010 W. Lehigh Avenue in North Philadelphia.
Thanks to a discovery by a Saint Louis University researcher, scientists have identified an important microRNA that may allow us to better control cholesterol levels in blood.
A novel study published in the American College of Rheumatology journal, Arthritis & Rheumatism, shows that smaller micropolitan areas of the U.S.-those with less than 50,000 people-have very few or no practicing adult rheumatologist. In some of these areas, individuals have to travel more than 200 miles to reach the closest rheumatologist.
Daiichi Sankyo Company, Limited today announced that it has started enrolling patients into the ENSURE-AF multinational phase 3 study, which will evaluate the efficacy and safety of its investigational oral, once-daily direct factor Xa-inhibitor edoxaban compared to enoxaparin/warfarin for the prevention of stroke and other blood clot complications in patients with non-valvular atrial fibrillation (NVAF) undergoing electrical cardioversion (low-energy shocks to trigger normal heart rhythm).
› Verified 1 days ago
| Entity Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
Bravo Health today announced that the first Bravo Health Advanced Care Center (the Center) will open in Philadelphia in January 2010. The Center, an innovative, state-of-the-art outpatient physician practice designed to meet the health care needs of Bravo Health members, will be located in a new building being constructed at 1010 W. Lehigh Avenue in North Philadelphia.
Thanks to a discovery by a Saint Louis University researcher, scientists have identified an important microRNA that may allow us to better control cholesterol levels in blood.
A novel study published in the American College of Rheumatology journal, Arthritis & Rheumatism, shows that smaller micropolitan areas of the U.S.-those with less than 50,000 people-have very few or no practicing adult rheumatologist. In some of these areas, individuals have to travel more than 200 miles to reach the closest rheumatologist.
Daiichi Sankyo Company, Limited today announced that it has started enrolling patients into the ENSURE-AF multinational phase 3 study, which will evaluate the efficacy and safety of its investigational oral, once-daily direct factor Xa-inhibitor edoxaban compared to enoxaparin/warfarin for the prevention of stroke and other blood clot complications in patients with non-valvular atrial fibrillation (NVAF) undergoing electrical cardioversion (low-energy shocks to trigger normal heart rhythm).
› Verified 1 days ago
| Entity Name | Gundersen Lutheran Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376593442 PECOS PAC ID: 2163331414 Enrollment ID: O20130619000254 |
News Archive
Bravo Health today announced that the first Bravo Health Advanced Care Center (the Center) will open in Philadelphia in January 2010. The Center, an innovative, state-of-the-art outpatient physician practice designed to meet the health care needs of Bravo Health members, will be located in a new building being constructed at 1010 W. Lehigh Avenue in North Philadelphia.
Thanks to a discovery by a Saint Louis University researcher, scientists have identified an important microRNA that may allow us to better control cholesterol levels in blood.
A novel study published in the American College of Rheumatology journal, Arthritis & Rheumatism, shows that smaller micropolitan areas of the U.S.-those with less than 50,000 people-have very few or no practicing adult rheumatologist. In some of these areas, individuals have to travel more than 200 miles to reach the closest rheumatologist.
Daiichi Sankyo Company, Limited today announced that it has started enrolling patients into the ENSURE-AF multinational phase 3 study, which will evaluate the efficacy and safety of its investigational oral, once-daily direct factor Xa-inhibitor edoxaban compared to enoxaparin/warfarin for the prevention of stroke and other blood clot complications in patients with non-valvular atrial fibrillation (NVAF) undergoing electrical cardioversion (low-energy shocks to trigger normal heart rhythm).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jimmy Viet Ninh, MD Po Box 735044, Chicago, IL 60673-5044 Ph: (800) 326-2250 | Dr Jimmy Viet Ninh, MD 10400 75th St, Kenosha, WI 53142-7884 Ph: (262) 948-7815 |
News Archive
Bravo Health today announced that the first Bravo Health Advanced Care Center (the Center) will open in Philadelphia in January 2010. The Center, an innovative, state-of-the-art outpatient physician practice designed to meet the health care needs of Bravo Health members, will be located in a new building being constructed at 1010 W. Lehigh Avenue in North Philadelphia.
Thanks to a discovery by a Saint Louis University researcher, scientists have identified an important microRNA that may allow us to better control cholesterol levels in blood.
A novel study published in the American College of Rheumatology journal, Arthritis & Rheumatism, shows that smaller micropolitan areas of the U.S.-those with less than 50,000 people-have very few or no practicing adult rheumatologist. In some of these areas, individuals have to travel more than 200 miles to reach the closest rheumatologist.
Daiichi Sankyo Company, Limited today announced that it has started enrolling patients into the ENSURE-AF multinational phase 3 study, which will evaluate the efficacy and safety of its investigational oral, once-daily direct factor Xa-inhibitor edoxaban compared to enoxaparin/warfarin for the prevention of stroke and other blood clot complications in patients with non-valvular atrial fibrillation (NVAF) undergoing electrical cardioversion (low-energy shocks to trigger normal heart rhythm).
› Verified 1 days ago
Dr. Pushparanee Babusukumar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3535 30th Ave, Suite 201, Kenosha, WI 53144 Phone: 262-652-7813 Fax: 262-652-4450 | |
Dr. Mathew Sean Mccarthy, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3536 52nd St, Kenosha, WI 53144 Phone: 262-657-1090 | |
Dr. Saritha Kundoor, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 | |
Anna Klyachkina, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12225 71st St, Kenosha, WI 53142 Phone: 262-948-4870 | |
Dr. Vanessa Q Chang, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, #307, Kenosha, WI 53142 Phone: 262-948-6770 | |
Ronald Rubin, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3734 7th Ave Ste 12, Kenosha, WI 53140 Phone: 262-654-9370 Fax: 262-654-9379 |